HK-Shenzhen pulls off a first under medical connect

    By Chai Hua | HK EDITION | Updated: 2021-05-21 14:26
    Share
    Share - WeChat
    Management teams from the University of Hong Kong-Shenzhen Hospital and China Resources Guangdong Pharmaceutical pose for a group photo with the first imported medicine and medical device under the connect on April 16. [Photo provided to China Daily]

    Moreover, he said the new channel can expand sales of medical companies. The hospital is purchasing a further 10 titanium rods. Each patient needs only one or two rods.

    Lo said safety concerns will ensure the quantity won't be extremely large initially. "The titanium rod producer has agreed to provide the equipment on the mainland because they knew Professor Cheung would perform the surgery," he added, stressing the result of each case is important for the drug and medical equipment producers.

    According to HKU-SZH, four other innovative medications have been approved and will soon be put into pilot use at the hospital, following the first drug and device applications.

    The first imported medicine under the connect program is Rho(D) immune globulin - a blood disease drug that was used clinically at the hospital on April 29. In addition, the clinical data collected from these applications could also help expedite national approval for related international drugs or devices.

    The marketing of many medicines in Hong Kong is synchronized with the world because of mutual recognition, but the mainland needs to do its own clinical results for review and approval, said Huo Peiqiong, general manager of China Resources Guangdong Pharmaceutical - the import agent for the first drugs and equipment.

    So registering in Hong Kong or launching the products in the Hong Kong market is much faster than on the mainland, she noted. For example, one drug can be listed in Hong Kong simultaneously in the United States or the United Kingdom.

    The connect gives the green light for medicines that are already available in Hong Kong and Macao markets, so more international pharmaceutical enterprises would seek registration there because entering the two special administrative regions mean they could tap the Greater Bay Area or the entire mainland market sooner.

    However, it wasn't plain sailing for reviewing, purchasing and transporting the first batch of drugs and device through the connect. Huo recalled it took more than two months to have them delivered.

    Many innovative measures were needed to lay a solid foundation for the potential expansion of the connect to more mainland cities. But in the absence of national approval, the import agent had to communicate back and forth between local evaluation authorities and pharmaceutical enterprises to provide proper materials for review.

    |<< Previous 1 2 3 4 Next   >>|
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    亚洲gv天堂无码男同在线观看| 亚洲精品无码乱码成人| 无码无套少妇毛多18p| 久久久久中文字幕| 久久无码人妻精品一区二区三区| 国产成人无码区免费内射一片色欲| 中文字幕乱偷无码AV先锋| 国产在线无码一区二区三区视频| 精品无码一区二区三区电影| 日本中文字幕网站| 亚洲AV无码乱码在线观看性色扶| 亚洲AV无码一区二区乱子伦| 人妻中文无码久热丝袜| 最新中文字幕在线视频| 亚洲AV无码专区在线播放中文| 91久久精品无码一区二区毛片| 无码人妻精品一区二区三| 无码国内精品久久综合88| 最近免费中文字幕高清大全 | 被夫の上司に犯中文字幕 | 久久精品无码专区免费青青| 少妇无码太爽了不卡在线观看| 日韩在线中文字幕| 色噜噜综合亚洲av中文无码| 最近中文字幕在线中文高清版| 无码国产成人午夜电影在线观看| av大片在线无码免费| 18禁无遮拦无码国产在线播放| 久久久久久久亚洲Av无码| 久久久久久亚洲AV无码专区| 国产乱人伦Av在线无码| av区无码字幕中文色| 97精品人妻系列无码人妻| 国产精品va在线观看无码| 国产精品无码专区在线观看| 精品亚洲成α人无码成α在线观看| 免费精品无码AV片在线观看 | 内射无码午夜多人| 亚洲AV无码专区日韩| 天堂√中文最新版在线| 亚洲中文字幕无码爆乳AV|